The C5b-6 complex: formation, isolation, and inhibition of its activity by lipoprotein and the S-protein of human serum.
about
Structure of Complement C6 Suggests a Mechanism for Initiation and Unidirectional, Sequential Assembly of Membrane Attack Complex (MAC)Complement inhibition by human vitronectin involves non-heparin binding domainsCharacterization of the complement sensitivity of paroxysmal nocturnal hemoglobinuria erythrocytes.Molecular cloning and characterization of the novel, human complement-associated protein, SP-40,40: a link between the complement and reproductive systemsInvolvement of antilipoarabinomannan antibodies in classical complement activation in tuberculosis.Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins.Membrane attack complex of complement: distribution of subunits between the hydrocarbon phase of target membranes and water.Apolipoprotein A-I exerts bactericidal activity against Yersinia enterocolitica serotype O:3SP-40,40, a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis.Antigenic crossreactivity of the alpha subunit of complement component C8 with the cysteine-rich domain shared by complement component C9 and low density lipoprotein receptor.The binding of human low-density lipoproteins to the surface of schistosomula of Schistosoma mansoni is inhibited by polyanions and reduces the binding of anti-schistosomal antibodiesLysis of complement-sensitive Entamoeba histolytica by activated terminal complement components. Initiation of complement activation by an extracellular neutral cysteine proteinasePRELP protein inhibits the formation of the complement membrane attack complex.Occurrence of an incomplete C8 molecule in homozygous C8 deficiency in manComplement activation, regulation, and molecular basis for complement-related diseasesMembrane attack complex of complement: generation of high-affinity phospholipid binding sites by fusion of five hydrophilic plasma proteins.Molecular reorganization of lipid bilayers by complement: a possible mechanism for membranolysisCytolysis of nucleated cells by complement: cell death displays multi-hit characteristics.Mechanism of YadA-mediated serum resistance of Yersinia enterocolitica serotype O3.Specific binding of the human S protein (vitronectin) to streptococci, Staphylococcus aureus, and Escherichia coli.Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells.Structural analysis of sulphated glycoprotein 2 from amino acid sequence. Relationship to clusterin and serum protein 40,40Membrane attack complex of complement: a structural analysis of its assembly.The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity.Physicochemical characterization of human S-protein and its function in the blood coagulation system.C5b-9 dimer: isolation from complement lysed cells and ultrastructural identification with complement-dependent membrane lesions.Vitronectin binds to the gonococcal adhesin OpaA through a glycosaminoglycan molecular bridge.
P2860
Q27676846-50703762-0CD7-4792-9E83-0CED63504610Q28611007-F4193197-E3D5-4BF8-9834-8243F9A6D85FQ30449395-4AE948F2-FB44-4860-B0A4-BF3B5F12A382Q33560792-9AD43C06-9B91-4154-8979-16F515FDE13DQ33991708-7AE6A4D9-3CC8-46E0-A007-771F76C3E6B3Q35205168-B3017E9E-03A0-4928-83A9-80432C6E63A7Q35408072-7B9ACBB2-1CD2-4DE6-9C1F-85149D4AB1FEQ35515462-04653E77-1D16-4DA0-9DE8-8E613EFC9BF3Q35589951-389A91B4-C291-48FC-B2F5-94CCE75FD746Q35610543-F528917A-B968-4333-83E5-36C03125EB46Q35816823-93D81D21-117A-4F81-BB1E-9ADE9B0A6493Q35816948-5020FB46-3CB3-45CD-BB3A-AA1FC4CB8BEAQ35868224-A1A28BC6-95F8-4042-9497-ED379F9856DCQ36345792-66526CAE-8485-4348-9989-DC83404575D2Q36380682-34F29D62-FF8C-4D3F-A899-65C3EC643A5EQ37316358-528300A2-8A7C-429B-B702-3E11FE845144Q37321360-0EE8D039-BFE5-4FCC-A086-18F3CFB7862BQ37615595-46872962-5DA4-411D-8535-48481C8B2D07Q40148586-5F7B997C-5F87-4722-8C23-D6BB2FCBB3FDQ40163829-5BEC8001-4D27-4DEC-9D15-1C35942BEA16Q40918020-9F04A0B2-7951-4752-92F1-852359F42968Q41189803-DBA18386-FE75-40B0-8DB5-73797114F363Q41905259-5D105BED-7395-482A-BCB6-85ABCDD2B10CQ41923727-AC6E230A-E712-411C-82DF-F6A973ACF0A8Q41961499-FB602640-8EB1-4FF5-BD34-1AE32D3796D0Q42933729-3046300D-8F4B-4E69-9ED6-AFCB49743E2DQ42991449-20FD0716-174A-40C1-BB57-B8D15452A454
P2860
The C5b-6 complex: formation, isolation, and inhibition of its activity by lipoprotein and the S-protein of human serum.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年学术文章
@wuu
1978年学术文章
@zh-cn
1978年学术文章
@zh-hans
1978年学术文章
@zh-my
1978年学术文章
@zh-sg
1978年學術文章
@yue
1978年學術文章
@zh
1978年學術文章
@zh-hant
name
The C5b-6 complex: formation, ...... the S-protein of human serum.
@en
The C5b-6 complex: formation, ...... the S-protein of human serum.
@nl
type
label
The C5b-6 complex: formation, ...... the S-protein of human serum.
@en
The C5b-6 complex: formation, ...... the S-protein of human serum.
@nl
prefLabel
The C5b-6 complex: formation, ...... the S-protein of human serum.
@en
The C5b-6 complex: formation, ...... the S-protein of human serum.
@nl
P2093
P1476
The C5b-6 complex: formation, ...... d the S-protein of human serum
@en
P2093
Müller-Eberhard HJ
P304
P407
P577
1978-06-01T00:00:00Z